Viability Reduction and <i>Rac1</i> Gene Downregulation of Heterogeneous <i>Ex-Vivo</i> Glioma Acute Slice Infected by the Oncolytic Newcastle Disease Virus Strain V4UPM

<table>EGAS viability progression analysis and subsequent assessment in an organotypic culture following the excision from the patient and maintenance as EGAS in aCSF for 7 hours (represented as 0 hour in organotypic culture), the NDV-V4UPM treated EGAS showed a significant** reduction in the number of viable cells until 48 hours but regrowth at 72 hours, whilst mock-infected EGAS showed persistent growth with an increased number of viable cells. Error bars represent the ±SE.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Viability Reduction and <i>Rac1</i> Gene Downregulation of Heterogeneous <i>Ex-Vivo</i> Glioma Acute Slice Infected by the Oncolytic Newcastle Disease Virus Strain V4UPM 

Figure 2 | Viability Reduction and Rac1 Gene Downregulation of Heterogeneous Ex-Vivo Glioma Acute Slice Infected by the Oncolytic Newcastle Disease Virus Strain V4UPM 